The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of tinengotinib in patients with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC).
 
Guo Hongqian
No Relationships to Disclose
 
Sumit Kumar Subudhi
Stock and Other Ownership Interests - Apricity Health
Consulting or Advisory Role - Amgen; Apricity Health; Arcus Biosciences,; AstraZeneca; Baird; Bayer; Boxer Capital; Breaking Data; Bristol-Myers Squibb; Cancer Expert Now; ChemoCentryx; Clinical Comms Group; Dava Oncology; Dendreon; InProTher Janssen; Janssen; Javelin Oncology; Kahr Medical Ltd; MD Education; Merck; OncLive (owned by Intellisphere, LLC); Pfizer; Polaris; Portage Biotech; Regeneron
Research Funding - AstraZeneca; Bristol-Myers Squibb; Janssen; Regeneron
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Regeneron
 
Weiqing Han
No Relationships to Disclose
 
Chih-Yi Liao
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Exelixis; Genentech; Histosonics; Incyte; Ipsen; Lexicon; Lilly; QED Therapeutics; TransThera Biosciences
Speakers' Bureau - AstraZeneca; Eisai; Exelixis; Incyte
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Exelixis; Incyte; Ipsen
 
Shun Zhang
No Relationships to Disclose
 
Tao Dai
No Relationships to Disclose
 
Peng Peng
Employment - TransThera Sciences (Nanjing), Inc.
Stock and Other Ownership Interests - TransThera Sciences (Nanjing), Inc.
Patents, Royalties, Other Intellectual Property - PCT/CN2022/091924 (Inst)
 
Caixia Sun
Employment - TransThera Sciences (Nanjing), Inc.
 
Hui Wang
No Relationships to Disclose
 
Katie Hennessy
Employment - TransThera Biosciences
Travel, Accommodations, Expenses - TransThera Biosciences
 
Ximei Fu
Employment - TransThera Sciences (Nanjing), Inc.
 
Yingying Yu
No Relationships to Disclose
 
Yingtong Wu
No Relationships to Disclose
 
Qing Li
Employment - TransThera Sciences (Nanjing), Inc.
 
Ruolan Xu
Employment - TransThera Sciences (Nanjing), Inc.
 
Peng Huang
Employment - TransThera Sciences (Nanjing), Inc.
 
Levin Neo
Employment - TransThera Sciences (Nanjing), Inc.
 
Frank Wu
Leadership - TransThera Sciences (Nanjing), Inc.
Stock and Other Ownership Interests - TransThera Sciences (Nanjing), Inc.
 
Jean Fan
Employment - TransThera Biosciences
Leadership - TransThera Biosciences
Stock and Other Ownership Interests - AstraZeneca
 
Sarina A. Piha-Paul
Consulting or Advisory Role - CRC Oncology
Research Funding - Abbvie (Inst); ABM (Inst); Acepodia (Inst); Alkermes (Inst); Aminex (Inst); Amphivena Therapetics, Inc. (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Bristol Myers Squib (Inst); Cerulean Pharma (Inst); Chugai Pharma (Inst); Curis (Inst); Cyclacel (Inst); Daichi Sanko (Inst); ENB Therapeutics (Inst); Epigenetix (Inst); F-Star Beta Limited (Inst); F-Star Therapeutics, Ltd. (Inst); Five Prime Therapeutics (Inst); Gene Quantum (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Helix BioPharma (Inst); Hengrui Pharmaceutical (Inst); HiberCell (Inst); Immorna (Inst); Immunomedics (Inst); Incyte (Inst); Jacobio (Inst); Jiangsu Simcere Pharmaceutical Co. Ltd. (Inst); Lilly (Inst); Lytix Biopharma (Inst); MedImmune (Inst); Medivation (Inst); Merck Sharp and Dohme Corp. (Inst); Nectin Therapeutics (Inst); NIH/NCI (Inst); Novartis (Inst); Pfizer (Inst); Phanes Therapeutics (Inst); Pieris Pharmaceuticals (Inst); Principa Biopharma (Inst); Puma Biotechnology (Inst); Purinomia (Inst); RAPT Therapeutics (Inst); Replimune (Inst); Seagen (Inst); Silverback Therapeutics (Inst); Synlogic (Inst); Taiho Oncology (Inst); Tesaro (Inst); TransThera Biosciences (Inst); ZielBio (Inst)